A phase-1 trial of intraperitoneal 5-fluorouracil and oxaliplatin in patients with colorectal cancer and unresectable peritoneal metastasis.

Medicine & Life Sciences

1. Oxaliplatin 100%
2. Fluorouracil 92%
3. Colorectal Neoplasms 72%
4. Drug Therapy 64%
5. Cytoreduction Surgical Procedures 62%
6. Neoplasm Metastasis 52%
7. Peritoneal Neoplasms 48%
8. Maximum Tolerated Dose 28%
9. Neoplasms 23%
10. Laparoscopy 22%
11. Response Evaluation Criteria in Solid Tumors 15%
12. Peritoneum 13%
13. Peritoneal Cavity 13%
14. Survival 13%
15. Proxy 12%
16. Combination Drug Therapy 12%
17. Tumor Biomarkers 11%
18. Flow Cytometry 9%
19. Cell Death 9%
20. Animal Models 8%
21. Biomarkers 7%
22. Biopsy 7%
23. Phenotype 7%
24. Morbidity 7%
25. Safety 7%
26. Recurrence 6%
27. Lung 6%
28. Liver 6%
29. Therapeutics 5%